SRNE Phase 2

SAN DIEGO, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 clinical trial of Abivertinib in mild, moderate and severe COVID-19 patients.

圣地亚哥，2020年10月14日（全球新闻）-Sorrento Therapeutics，Inc.（纳斯达克股票代码：SRNE，“ Sorrento”）今天宣布已收到巴西监管机构（ANVISA）的批准，以进行该药物的2期临床试验 轻度，中度和重度COVID-19患者中的Abivertinib。

 

所有跟帖： 

• 老季盘后不欢实啊 -就爱喝酒的家伙- ♂ (0 bytes) () 10/14/2020 postreply 13:45:29

• 盘前就有的消息 -飞飞54321- ♂ (0 bytes) () 10/14/2020 postreply 13:46:00

• 我一激动，又买回来了。 -bubbleberry- ♂ (0 bytes) () 10/14/2020 postreply 13:47:26

• 盘后得量好大，是卖还是买？ -bubbleberry- ♂ (0 bytes) () 10/14/2020 postreply 13:46:52

• 哈哈，我看到的是一天的量吧？ -bubbleberry- ♂ (0 bytes) () 10/14/2020 postreply 13:54:11

• 好消息只是刚刚开始 -majiaking- ♀ (282 bytes) () 10/14/2020 postreply 14:00:18